Real-world efficacy of "fixed triple" single-inhaler combinations in COPD and asthma patients

被引：0
|
作者：
Mochizuki, Taichi [1 ]
Arai, Hiroyuki [1 ]
Inoue, Yasushi [1 ]
Ueda, Ryuta [1 ]
Nagase, Seisuke [1 ]
Umeda, Akira [2 ]
To, Yasuo [3 ]
Tsushima, Kenji [3 ]
机构：
[1] IUHW Int Univ Hlth & Welf, Resp Dis Ctr, Mita Hosp, Tokyo, Japan
[2] IUHW Shioya Hosp, Dept Resp Med, Yaita, Japan
[3] IUHW Narita Hosp, Dept Pulm Med, Narita, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP09-305
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [41] A SYSTEMATIC REVIEW OF SINGLE-INHALER TRIPLE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Langham, S.
    Lewis, J.
    Pooley, N.
    Embleton, N.
    Langham, J.
    VALUE IN HEALTH, 2019, 22 : S873 - S873
  • [42] Trioptimize VI: The Use of Extrafine Single Inhaler Triple Therapy Improves Adherence to Treatment in Patients with COPD - Real-World Evidence
    Hoevelmann, R.
    Georges, G.
    Javan, S. Bahari
    Melchior, K.
    Criee, C.
    Gessner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [43] REDUCED HEALTH CARE RESOURCE UTILISATION AND COSTS FOLLOWING A SWITCH FROM MULTIPLE-INHALER TO ONCE-DAILY SINGLE-INHALER TRIPLE THERAPY IN COPD PATIENTS IN A REAL-WORLD PRIMARY CARE SETTING IN ENGLAND
    Rothnie, K. J.
    Wood, R. P.
    Czira, A.
    Banks, V. L.
    Cammidge, L. J.
    Massey, O. K.
    Seif, M.
    Compton, C.
    Sharma, R.
    Ismaila, A. S.
    VALUE IN HEALTH, 2022, 25 (12) : S484 - S484
  • [44] Cost-effectiveness analysis of a single-inhaler triple therapy for COPD in the UK
    Fenwick, Elisabeth
    Martin, Alan
    Schroeder, Melanie
    Mealing, Stuart J.
    Solanke, Oyinkansola
    Risebrough, Nancy
    Ismaila, Afisi S.
    ERJ OPEN RESEARCH, 2021, 7 (01)
  • [45] Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management
    Averell, Carlyne M.
    Busse, William W.
    Abbott, Carl B.
    Germain, Guillaume
    MacKnight, Sean D.
    Jung, Young
    Duh, Mei Sheng
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (11): : 2904 - +
  • [46] Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study
    Rothnie, Kieran J.
    Wood, Robert P.
    Czira, Alexandrosz
    Banks, Victoria L.
    Camidge, Lucinda J.
    Massey, Olivia K., I
    Seif, Monica
    Compton, Chris
    Sharma, Raj
    Halpin, David M. G.
    Ismaila, Afisi S.
    Vogelmeier, Claus F.
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [47] Real-World Effectiveness of Fluticasone Furoate/ Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial
    Beeh, Kai -Michael
    Scheithe, Karl
    Schmutzler, Heike
    Krueger, Saskia
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 205 - 216
  • [48] Single-Inhaler Triple vs Long-Acting Beta2-Agonist-Inhaled Corticosteroid Therapy for COPD Comparative Safety in Real-World Clinical Practice
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    CHEST, 2025, 167 (03) : 712 - 723
  • [49] Effect on asthma control in patients with asthma and concomitant COPD after three months of treatment with extrafine formulation single-inhaler triple therapy TriMaximize study
    Timmermann, Hartmut
    Akyildiz, Berktan
    Bogoevska, Valentina
    Russell, Richard
    Nachtigall, Detlef
    Pohl, Wolfgang
    Ulrik, Charlotte Suppli
    Wendt, Andreas
    Gessner, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [50] Real-world impact of non-clinical inhaler switching on asthma or COPD patients: A systematic review
    Bell, John
    Usmani, Omar
    Bosnic-Anticevich, Sinthia
    Dekhuijzen, Richard
    Lavorini, Federico
    Stjepanovic, Neda
    Swift, Stephanie L.
    Roche, Nicolas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 344 - 345
12345